Chemical Component Summary

Name~{N}-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-methyl-4-oxidanyl-piperidine-1-carboxamide
Identifiers~{N}-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-methyl-4-oxidanyl-piperidine-1-carboxamide
FormulaC19 H26 N4 O4 S
Molecular Weight406.499
TypeNON-POLYMER
Isomeric SMILESCC1(CCN(CC1)C(=O)Nc2nc3c(ccc(c3s2)N4CCOCC4)OC)O
InChIInChI=1S/C19H26N4O4S/c1-19(25)5-7-23(8-6-19)18(24)21-17-20-15-14(26-2)4-3-13(16(15)28-17)22-9-11-27-12-10-22/h3-4,25H,5-12H2,1-2H3,(H,20,21,24)
InChIKeyXNBRWUQWSKXMPW-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count54
Chiral Atom Count0
Bond Count57
Aromatic Bond Count10

Drug Info: DrugBank

DrugBank IDDB12203 
NameTozadenant
Groups investigational
DescriptionTozadenant has been investigated for the basic science of Cocaine Dependence.
SynonymsTozadenant
Categories
  • Heterocyclic Compounds, Fused-Ring
  • Thiazoles
CAS number870070-55-6

Related Resource References

Resource NameReference
Pharos CHEMBL2105747
PubChem 11618368
ChEMBL CHEMBL2105747